药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cysteamine
Indiplon
The risk or severity of adverse effects can be increased when Clomipramine is combined with Indiplon.
Cysteamine
AZD-3043
The risk or severity of adverse effects can be increased when Clomipramine is combined with AZD-3043.
Cysteamine
Piritramide
The risk or severity of adverse effects can be increased when Clomipramine is combined with Piritramide.
Cysteamine
Ketanserin
The risk or severity of adverse effects can be increased when Clomipramine is combined with Ketanserin.
Cysteamine
Orvepitant
The risk or severity of adverse effects can be increased when Clomipramine is combined with Orvepitant.
Cysteamine
Esreboxetine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Esreboxetine.
Cysteamine
Piclozotan
The risk or severity of adverse effects can be increased when Clomipramine is combined with Piclozotan.
Cysteamine
Carisbamate
The risk or severity of adverse effects can be increased when Clomipramine is combined with Carisbamate.
Cysteamine
Eltanolone
The risk or severity of adverse effects can be increased when Clomipramine is combined with Eltanolone.
Cysteamine
Cerlapirdine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Cerlapirdine.
Cysteamine
Eplivanserin
The risk or severity of adverse effects can be increased when Clomipramine is combined with Eplivanserin.
Cysteamine
Sarpogrelate
The risk or severity of adverse effects can be increased when Clomipramine is combined with Sarpogrelate.
Cysteamine
MK-212
The risk or severity of adverse effects can be increased when Clomipramine is combined with MK-212.
Cysteamine
m-Chlorophenylpiperazine
The risk or severity of adverse effects can be increased when Clomipramine is combined with m-Chlorophenylpiperazine.
Cysteamine
Imagabalin
The risk or severity of adverse effects can be increased when Clomipramine is combined with Imagabalin.
Cysteamine
Vabicaserin
The risk or severity of adverse effects can be increased when Clomipramine is combined with Vabicaserin.
Cysteamine
Idalopirdine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Idalopirdine.
Cysteamine
Lanicemine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Lanicemine.
Cysteamine
Etiracetam
The risk or severity of adverse effects can be increased when Clomipramine is combined with Etiracetam.
Cysteamine
Brexanolone
The risk or severity of adverse effects can be increased when Clomipramine is combined with Brexanolone.